Navigation Links
IDEV Technologies Introduces SurePath™ Guidewires
Date:6/8/2012

WEBSTER, Texas, June 8, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV), an emerging innovator in peripheral vascular devices, announced the United States introduction and launch of a new line of interventional guidewires manufactured with a proprietary alloy combining strength with flexibility.

The SurePath™ Guidewires are intended for everyday use in peripheral and coronary procedures, and were developed to be stronger than standard nitinol wires while simultaneously being more flexible than standard stainless steel wires.  The proprietary SurePath alloy displays excellent kink resistance, pushability, and steerability.

"We're excited to introduce these wires to the market," commented Trent Reutiman, IDEV's Vice President of Global Commercial Operations.  "Different catheter-based procedures and physician preferences demand a range of guidewire characteristics and we believe that SurePath fills a significant gap in the marketplace for a device with a unique combination of strength and flexibility. SurePath is another example of IDEV bringing to market differentiated products that make a real difference to physicians and patients."

Dr. Matthew Selmon from Austin Heart in Austin, TX remarked, "The shapeable tip holds well, and the torque was excellent.  The wire works well as an everyday workhorse guidewire." 

The SurePath Guidewires will be introduced at the New Cardiovascular Horizons annual meeting in New Orleans June 6th-9th, and are available for sale throughout the United States.

This latest product introduction is consistent with the strategic vision and direction of the company.  "The SurePath Guidewire is unique to the market, and we will continue to expand our product platforms as we find appropriate applications of existing technology, or develop new products that deliver clear patient benefits," said Christopher M. Owens, President and CEO. 

About IDEV Technologies, IncorporatedIDEV Technologies, Incorporated (IDEV) is an innovator and developer of next generation medical devices for use in interventional radiology, vascular surgery and cardiology.  IDEV's worldwide headquarters is located in Webster, Texas and its European headquarters is located in Beuningen, The Netherlands.

For more information please visit www.idevmd.com. Contact:Donna LucchesiVice President Global MarketingIDEV Technologies, Incorporated(281) 525-2000 


'/>"/>

SOURCE IDEV Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
2. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
3. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
4. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
5. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets
6. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
7. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
8. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
9. MedClean Technologies Announces 2011 Results
10. Patient Safety Technologies Reports First Quarter 2012 Results
11. Breathe Technologies Non-Invasive Open Ventilation (NIOV™) System Receives Medical Design Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... , February 9, 2016 ... QIA) gab heute den Abschluss eines Kooperationsvertrags ... Förderung umfassender Lösungen in den Bereichen Next-Generation-Sequencing ... QGEN ; Frankfurt Prime Standard: QIA) ... 10x Genomics für die Entwicklung und Förderung ...
(Date:2/9/2016)... 9, 2016 Mast Therapeutics, Inc. (NYSE ... sickle cell disease and heart failure, today announced that it ... purchase common stock in an underwritten public offering.  The offering ... be no assurance as to whether or when the offering ... terms of the offering.   --> ...
(Date:2/9/2016)... 9, 2016 Hearing protection devices refer to ... transmitted to the inner ear. Hearing protection devices include ... devices are recommended for users exposed to noise levels ... to HPD that are inserted in the ear canal ... to provide more natural sound perception with the help ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... ... Establishment Labs, a global breast implant and medical technology company, is pleased ... , “We are honored to welcome David to our Board of Directors. ... Quiros, CEO of Establishment Labs. "David’s knowledge and experience will be invaluable to our ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... service to expand access to affordable hearing aids , increase industry transparency, ... individuals in the United States. , “For the average consumer, the hearing aid ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... sealing company , is proud to announce that many of their franchises have ... customer service. The hard surface restoration franchises received customer recognition through positive reviews ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory ... federallabs.org . The site houses a wealth of federal resources that businesses can ... process called technology transfer (T2). As a network of over 300 federal laboratories, ...
(Date:2/8/2016)... Los Angeles, CA (PRWEB) , ... February 08, 2016 , ... A man who has ... CEO of Freedom Laser Therapy , was determined to find solutions to his problems ... story of Inventors Digest is ready to introduce his breakthrough inventions to the ...
Breaking Medicine News(10 mins):